Skip to main content

Cardinal Health income statement

  • CAH · NYSE
  • Distribution
  • Health Care Distributors
  • S&P 500
$281.10+1.06%Close 13 Nov 2026 · Market value $65.45B

Cardinal Health reported revenue of $254.2 billion for fiscal year 2026 (the twelve months to 30 Jun 2026), up 14.2% from fiscal 2025. Net income was $1.71 billion and diluted earnings per share $7.23.

From Cardinal Health's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 30 Jun 2026. TTM is the last four reported quarters added up.

Annual

Cardinal Health income statement, annual
USDFY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026TTM
Revenue$95.99B$98.50B$102.6B$107.6B$101.1B$91.08B$102.5B$121.5B$130.0B$136.8B$145.5B$152.9B$162.5B$181.3B$205.0B$226.8B$222.6B$254.2B$257.8B
Revenue growth—+2.6%+4.2%+4.8%−6.0%−9.9%+12.6%+18.5%+6.9%+5.3%+6.4%+5.1%+6.2%+11.6%+13.0%+10.7%−1.9%+14.2%—
Cost of revenue$92.24B$94.72B$98.48B$103.0B$96.17B$85.92B$96.82B$115.0B$123.4B$129.6B$138.7B$146.1B$155.7B$174.8B$198.1B$219.4B$214.4B$244.5B$247.7B
Gross profit$3.75B$3.78B$4.16B$4.54B$4.92B$5.16B$5.71B$6.54B$6.54B$7.18B$6.83B$6.87B$6.78B$6.48B$6.87B$7.41B$8.17B$9.77B$10.05B
Gross margin3.9%3.8%4.1%4.2%4.9%5.7%5.6%5.4%5.0%5.2%4.7%4.5%4.2%3.6%3.4%3.3%3.7%3.8%3.9%
Selling, general and administrative$2.33B$2.40B$2.53B$2.68B$2.88B$3.03B$3.24B$3.65B$3.77B$4.60B$4.48B$4.57B$4.53B$4.51B$4.80B$5.00B$5.38B$6.13B$6.27B
Operating income$1.29B$1.31B$1.51B$1.79B$996.0M$1.89B$2.16B$2.46B$2.12B$126.0M$2.06B−$4.10B$472.0M−$607.0M$752.0M$1.24B$2.27B$2.61B$2.70B
Operating margin1.3%1.3%1.5%1.7%1.0%2.1%2.1%2.0%1.6%0.1%1.4%−2.7%0.3%−0.3%0.4%0.5%1.0%1.0%1.0%
Interest expense$114.4M$113.0M$93.00M$95.00M$123.0M$133.0M$141.0M$178.0M$201.0M$329.0M$294.0M$238.0M$180.0M$147.0M$84.00M$51.00M$215.0M$348.0M$341.0M
Income before tax$1.16B$1.21B$1.52B$1.70B$888.0M$1.80B$1.97B$2.28B$1.92B−$228.0M$1.75B−$3.77B$323.0M−$784.0M$663.0M$1.20B$2.10B$2.17B$2.26B
Income tax expense$401.6M$625.0M$552.0M$628.0M$553.0M$635.0M$755.0M$845.0M$630.0M−$487.0M$386.0M−$79.00M−$289.0M$153.0M$332.0M$348.0M$532.0M$469.0M$457.0M
Effective tax rate34.6%51.6%36.4%37.0%62.3%35.3%38.4%37.1%32.7%214%22.0%2.1%−89.5%−19.5%50.1%29.0%25.3%21.6%20.2%
Net income$1.15B$642.0M$959.0M$1.07B$334.0M$1.17B$1.22B$1.43B$1.29B$256.0M$1.36B−$3.70B$611.0M−$938.0M$330.0M$852.0M$1.56B$1.71B$1.82B
Net margin1.2%0.7%0.9%1.0%0.3%1.3%1.2%1.2%1.0%0.2%0.9%−2.4%0.4%−0.5%0.2%0.4%0.7%0.7%0.7%
EPS · diluted$3.18$1.77$2.72$3.06$0.97$3.38$3.62$4.32$4.03$0.81$4.53−$12.61$2.08−$3.37$1.26$3.45$6.45$7.23$7.73
Diluted weighted average shares362M361M353M349M344M345M335M330M320M315M301M293M294M279M262M247M242M237M235M
Basic weighted average shares358M359M349M345M341M341M332M327M317M313M300M293M292M279M261M245M241M236M234M
EBITDA$1.51B$1.56B$1.83B$2.12B$1.39B$2.34B$2.61B$3.10B$2.84B$1.16B$3.06B−$3.19B$1.25B$85.00M$1.44B$1.95B$3.06B$3.57B$3.67B
EBITDA margin1.6%1.6%1.8%2.0%1.4%2.6%2.5%2.6%2.2%0.8%2.1%−2.1%0.8%0.0%0.7%0.9%1.4%1.4%1.4%
Depreciation & amortization$225.8M$254.0M$313.0M$325.0M$397.0M$459.0M$451.0M$641.0M$717.0M$1.03B$1.00B$913.0M$783.0M$692.0M$692.0M$710.0M$790.0M$956.0M$970.0M
Stock-based compensation$109.9M$100.0M$80.00M$85.00M$93.00M$96.00M$110.0M$111.0M$96.00M$85.00M$82.00M$90.00M$89.00M$81.00M$96.00M$121.0M$244.0M$367.0M$383.0M
Dividends per share$0.56$0.70$0.78$0.86$1.02$1.21$1.37$1.55$1.80$1.85$1.91$1.92$1.94$1.96$1.98$2.00$2.02$2.04—

Quarterly

Cardinal Health income statement, quarterly
USDQ2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Revenue$57.44B$54.87B$59.87B$52.28B$55.26B$54.88B$60.16B$64.01B$65.63B$60.94B$63.67B$67.51B
Cost of revenue$55.59B$52.93B$57.98B$50.38B$53.32B$52.76B$57.96B$61.69B$63.23B$58.44B$61.11B$64.92B
Gross profit$1.85B$1.94B$1.88B$1.90B$1.94B$2.12B$2.20B$2.32B$2.40B$2.50B$2.56B$2.60B
Gross margin3.2%3.5%3.1%3.6%3.5%3.9%3.7%3.6%3.7%4.1%4.0%3.8%
Selling, general and administrative$1.27B$1.27B$1.28B$1.28B$1.31B$1.31B$1.48B$1.46B$1.50B$1.54B$1.63B$1.59B
Operating income$505.0M$369.0M$401.0M$568.0M$549.0M$730.0M$428.0M$668.0M$707.0M$509.0M$729.0M$753.0M
Operating margin0.9%0.7%0.7%1.1%1.0%1.3%0.7%1.0%1.1%0.8%1.1%1.1%
Interest expense$3.00M$28.00M$9.00M$32.00M$35.00M$74.00M$74.00M$80.00M$88.00M——$73.00M
Income before tax$512.0M$342.0M$391.0M$541.0M$511.0M$665.0M$384.0M$598.0M$630.0M$392.0M$554.0M$688.0M
Income tax expense$143.0M$80.00M$158.0M$124.0M$110.0M$157.0M$141.0M$144.0M$159.0M$12.00M$154.0M$132.0M
Effective tax rate27.9%23.4%40.4%22.9%21.5%23.6%36.7%24.1%25.2%3.1%27.8%19.2%
Net income$368.0M$261.0M$235.0M$416.0M$400.0M$506.0M$239.0M$450.0M$467.0M$399.0M$398.0M$554.0M
Net margin0.6%0.5%0.4%0.8%0.7%0.9%0.4%0.7%0.7%0.7%0.6%0.8%
EPS · diluted$1.50$1.07$0.95$1.70$1.65$2.10$1.00$1.88$1.97$1.69$1.70$2.38
Diluted weighted average shares246M245M247M245M243M241M239M239M237M236M234M233M
Basic weighted average shares245M243M245M243M242M240M238M238M236M235M233M232M
EBITDA$680.0M$546.0M$587.0M$750.0M$741.0M$937.0M$637.0M$901.0M$941.0M$757.0M$970.0M$1.00B
EBITDA margin1.2%1.0%1.0%1.4%1.3%1.7%1.1%1.4%1.4%1.2%1.5%1.5%
Depreciation & amortization$175.0M$177.0M$186.0M$182.0M$192.0M$207.0M$209.0M$233.0M$234.0M$248.0M$241.0M$247.0M
Stock-based compensation$28.00M$31.00M$33.00M$30.00M$30.00M$31.00M$153.0M$93.00M$87.00M$129.0M$58.00M$109.0M
Dividends per share———————————$0.52

The main figures as JSON and plain text. See data and methodology.

CAH in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.